Boothbay Fund Management, LLC Glycomimetics Inc Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$1.13 - $2.54 $14,084 - $31,658
12,464 New
12,464 $29,000
Q2 2020

Aug 14, 2020
SELL
$2.06 - $3.76 $27,604 - $50,384
-13,400 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$1.83 - $5.41 $24,522 - $72,494
13,400 New
13,400 $31,000
Q4 2019

Feb 14, 2020
SELL
$4.03 - $6.5 $120,900 - $195,000
-30,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$2.8 - $12.85 $84,000 - $385,500
30,000 New
30,000 $129,000

Others Institutions Holding GLYC

# of Institutions
35
Shares Held
17.8M
Call Options Held
0
Put Options Held
0
View Full List

About GLYCOMIMETICS INC

GLYC Quotes by TradingView
  • Ticker GLYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,423,900
  • Market Cap $16.8M
  • Description
  • GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...
More about GLYC
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email